On Wednesday, August 29, we became aware of Alcon's decision to issue a voluntary universal withdrawal of the CyPass Micro-Stent. Click here to read the press release from Alcon. We immediately took action to discontinue use of this implant and adapted surgical plans for patients scheduled for this procedure to best address the patients' medical needs. We expect further information from Alcon to be delivered to practices which have used the micro-stents in the next week to 10 business days. In the meanwhile, patients are to continue their originally-prescribed regimen following their CyPass implant procedure and keep all follow-up appointments for post-operative care to ensure continued positive outcomes. Patients may potentially receive further communication from Alcon regarding this matter and what, if any, action the patient must take in response. As soon as we receive clinical guidance from Alcon, we will partner with our experienced surgeons to develop a protocol for evaluation and surveillance of potential risk factors associated with these devices in patients who have already undergone this procedure.
0 Comments
Leave a Reply. |
AuthorThe staff and doctors at VisionAmerica are committed to providing relevant information for you, your patients and your practice. We hope you find the information in our blog post helpful. Archives
August 2019
Categories |